Home/Filings/4/0001193805-11-001067
4//SEC Filing

RIGEL PHARMACEUTICALS INC 4

Accession 0001193805-11-001067

$RIGLCIK 0001034842operating

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 5:27 PM ET

Size

39.5 KB

Accession

0001193805-11-001067

Insider Transaction Report

Form 4
Period: 2011-05-26
Flynn James E
10% OwnerOther
Transactions
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+46,524$372,192470,425 total(indirect: Through Deerfield Special Situations Fund, L.P.)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+72,800$582,400762,700 total(indirect: Through Deerfield Special Situations Fund International Limited)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+301,424$2,411,3923,204,167 total(indirect: Through Deerfield International Limited)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+229,252$1,834,0162,279,997 total(indirect: Through Deerfield Partners, L.P.)
Holdings
  • Common Stock

    25,000
DEERFIELD CAPITAL LP
10% OwnerOther
Transactions
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+229,252$1,834,0162,279,997 total(indirect: Through Deerfield Partners, L.P.)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+72,800$582,400762,700 total(indirect: Through Deerfield Special Situations Fund International Limited)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+301,424$2,411,3923,204,167 total(indirect: Through Deerfield International Limited)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+46,524$372,192470,425 total(indirect: Through Deerfield Special Situations Fund, L.P.)
Holdings
  • Common Stock

    25,000
Transactions
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+72,800$582,400762,700 total(indirect: Through Deerfield Special Situations Fund International Limited)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+229,252$1,834,0162,279,997 total(indirect: Through Deerfield Partners, L.P.)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+46,524$372,192470,425 total(indirect: Through Deerfield Special Situations Fund, L.P.)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+301,424$2,411,3923,204,167 total(indirect: Through Deerfield International Limited)
Holdings
  • Common Stock

    25,000
Transactions
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+229,252$1,834,0162,279,997 total(indirect: Through Deerfield Partners, L.P.)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+46,524$372,192470,425 total(indirect: Through Deerfield Special Situations Fund, L.P.)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+301,424$2,411,3923,204,167 total(indirect: Through Deerfield International Limited)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+72,800$582,400762,700 total(indirect: Through Deerfield Special Situations Fund International Limited)
Holdings
  • Common Stock

    25,000
Transactions
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+46,524$372,192470,425 total(indirect: Through Deerfield Special Situations Fund, L.P.)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+72,800$582,400762,700 total(indirect: Through Deerfield Special Situations Fund International Limited)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+229,252$1,834,0162,279,997 total(indirect: Through Deerfield Partners, L.P.)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+301,424$2,411,3923,204,167 total(indirect: Through Deerfield International Limited)
Holdings
  • Common Stock

    25,000
Transactions
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+46,524$372,192470,425 total(indirect: Through Deerfield Special Situations Fund, L.P.)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+301,424$2,411,3923,204,167 total(indirect: Through Deerfield International Limited)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+72,800$582,400762,700 total(indirect: Through Deerfield Special Situations Fund International Limited)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+229,252$1,834,0162,279,997 total(indirect: Through Deerfield Partners, L.P.)
Holdings
  • Common Stock

    25,000
Transactions
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+301,424$2,411,3923,204,167 total(indirect: Through Deerfield International Limited)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+46,524$372,192470,425 total(indirect: Through Deerfield Special Situations Fund, L.P.)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+72,800$582,400762,700 total(indirect: Through Deerfield Special Situations Fund International Limited)
  • Purchase

    Common Stock

    2011-05-26$8.00/sh+229,252$1,834,0162,279,997 total(indirect: Through Deerfield Partners, L.P.)
Holdings
  • Common Stock

    25,000
Footnotes (3)
  • [F1]This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons").
  • [F2]Deerfield Capital, L.P. is the general partner of Deerfield Special Situations Fund, L.P. and Deerfield Partners, L.P. (the "Onshore Funds"). James E. Flynn is the managing member of the general partner of Deerfield Capital, L.P. In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Onshore Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
  • [F3]Deerfield Management Company, L.P. is the investment manager of Deerfield Special Situations Fund International Limited and Deerfield International Limited (the "Offshore Funds"). James E. Flynn is the managing member of the general partner of Deerfield Management Company, L.P. In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Offshore Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Issuer

RIGEL PHARMACEUTICALS INC

CIK 0001034842

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001034842

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 5:27 PM ET
Size
39.5 KB